Literature DB >> 6548728

Effects of high calcium intake on blood pressure and calcium metabolism in young SHR.

N Stern, D B Lee, V Silis, F W Beck, L Deftos, S C Manolagas, J R Sowers.   

Abstract

Increased dietary calcium intake in the adult spontaneously hypertensive rat (SHR) has been reported to correct low serum ionized calcium concentration ([Ca++]) and to result in a significant amelioration of the prevailing hypertension. In the present study we examined several parameters of calcium metabolism in young (6-week-old) SHR and compared them with those observed in normotensive Wistar-Kyoto (WKY) rats fed equal amounts of a diet containing normal quantities of calcium (0.4%, wt/wt) for 4 weeks. A separate group of SHR was placed on an equal amount of a high calcium (2.8%, wt/wt) but otherwise identical diet. In SHR and WKY eating a normal calcium diet, serum total calcium concentration was not different, but [Ca++] was lower in SHR (1.58 +/- 0.06 vs 1.91 +/- 0.07 mmol/liter, p less than 0.01). Serum immunoreactive parathyroid hormone (PTH) was increased in some, but not all, SHR. No difference was noted between the two groups in the following parameters: calcium intake, serum 1,25 dihydroxycholecalciferol (1,25(OH)2D3), urinary calcium excretion, fractional stool calcium content ([stool calcium/calcium intake] X 100), and in vitro 45Ca uptake by everted gut sacs constructed from segments of duodenum, mid-jejunum, ileum, and proximal colon. A high calcium diet corrected the abnormal serum [Ca++] and PTH but did not alter the progression or severity of the hypertension in SHR. A lower net weight gain was observed in SHR on a high calcium diet when compared to SHR eating normal calcium diet (9.1 +/- 1.8 vs 27.0 +/- 2.0 g).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548728     DOI: 10.1161/01.hyp.6.5.639

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Maternal involvement in the development of cardiovascular phenotype.

Authors:  R McCarty; M A Cierpial; C A Murphy; J H Lee; C Fields-Okotcha
Journal:  Experientia       Date:  1992-04-15

2.  Increased calcium absorption in prehypertensive spontaneously hypertensive rat. Role of serum 1,25-dihydroxyvitamin D3 levels and intestinal brush border membrane fluidity.

Authors:  K Lau; C B Langman; U Gafter; P K Dudeja; T A Brasitus
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  The hemodynamic effect of dietary calcium supplementation on rat renovascular hypertension.

Authors:  R G Benedetti; K J Wise; L K Massey
Journal:  Basic Res Cardiol       Date:  1993 Jan-Feb       Impact factor: 17.165

4.  Parathyroid hormone-like protein is a secretory product of atrial myocytes.

Authors:  L J Deftos; D W Burton; D W Brandt
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Altered vitamin D metabolism in the kidney of the spontaneously hypertensive rat.

Authors:  H Kawashima
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

6.  Increased plasma calcitonin levels in young spontaneously hypertensive rats: role in disturbed phosphate homeostasis.

Authors:  R J Bindels; L A van den Broek; M J Jongen; W H Hackeng; C W Löwik; C H van Os
Journal:  Pflugers Arch       Date:  1987-04       Impact factor: 3.657

7.  Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control.

Authors:  P A Lucas; R C Brown; T Drüeke; B Lacour; J A Metz; D A McCarron
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

8.  High calcium intake does not prevent stress-salt hypertension in dogs.

Authors:  D E Anderson; P Murphy; W Kearns
Journal:  Pavlov J Biol Sci       Date:  1986 Jan-Mar

9.  The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III.

Authors:  Mieke Van Hemelrijck; Thurkaa Shanmugalingam; Cecilia Bosco; Wahyu Wulaningsih; Sabine Rohrmann
Journal:  Endocr Connect       Date:  2015-09       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.